These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22321844)

  • 1. [Human stool vimentin, oncostatin M receptor and tissue factor pathway inhibitor 2 gene methylation analysis for the detection of colorectal neoplasms].
    Zhang JP; Wang J; Gui YL; Zhu QQ; Xu ZW; Li JS
    Zhonghua Yi Xue Za Zhi; 2011 Sep; 91(35):2482-4. PubMed ID: 22321844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stool methylation-specific polymerase chain reaction assay for the detection of colorectal neoplasia in Korean patients.
    Baek YH; Chang E; Kim YJ; Kim BK; Sohn JH; Park DI
    Dis Colon Rectum; 2009 Aug; 52(8):1452-9; discussion 1459-63. PubMed ID: 19617759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypermethylation of ITGA4, TFPI2 and VIMENTIN promoters is increased in inflamed colon tissue: putative risk markers for colitis-associated cancer.
    Gerecke C; Scholtka B; Löwenstein Y; Fait I; Gottschalk U; Rogoll D; Melcher R; Kleuser B
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2097-107. PubMed ID: 25902909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of methylated tissue factor pathway inhibitor 2 and human long DNA in fecal samples of patients with colorectal cancer in China.
    Zhang J; Yang S; Xie Y; Chen X; Zhao Y; He D; Li J
    Cancer Epidemiol; 2012 Feb; 36(1):73-7. PubMed ID: 21621497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypermethylation of SFRP2 as a potential marker for stool-based detection of colorectal cancer and precancerous lesions.
    Huang Z; Li L; Wang J
    Dig Dis Sci; 2007 Sep; 52(9):2287-91. PubMed ID: 17410438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel methylation panel for the early detection of colorectal tumors in stool DNA.
    Azuara D; Rodriguez-Moranta F; de Oca J; Soriano-Izquierdo A; Mora J; Guardiola J; Biondo S; Blanco I; Peinado MA; Moreno V; Esteller M; Capellá G
    Clin Colorectal Cancer; 2010 Jul; 9(3):168-76. PubMed ID: 20643622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel method to capture methylated human DNA from stool: implications for colorectal cancer screening.
    Zou H; Harrington J; Rego RL; Ahlquist DA
    Clin Chem; 2007 Sep; 53(9):1646-51. PubMed ID: 17712002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of promoter methylation in stool: a novel method for the detection of colorectal cancer.
    Lenhard K; Bommer GT; Asutay S; Schauer R; Brabletz T; Göke B; Lamerz R; Kolligs FT
    Clin Gastroenterol Hepatol; 2005 Feb; 3(2):142-9. PubMed ID: 15704048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gene methylation in stool for the screening of colorectal cancer and pre-malignant lesions].
    Kang YP; Cao FA; Chang WJ; Lou Z; Wang H; Wu LL; Fu CG; Cao GW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Jan; 14(1):52-6. PubMed ID: 21271382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of methylation-sensitive high-resolution melting (MS-HRM) for the detection of stool DNA methylation in colorectal neoplasms.
    Xiao Z; Li B; Wang G; Zhu W; Wang Z; Lin J; Xu A; Wang X
    Clin Chim Acta; 2014 Apr; 431():154-63. PubMed ID: 24518356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review and quantitative assessment of methylation biomarkers in fecal DNA and colorectal cancer and its precursor, colorectal adenoma.
    Liu R; Su X; Long Y; Zhou D; Zhang X; Ye Z; Ma J; Tang T; Wang F; He C
    Mutat Res Rev Mutat Res; 2019; 779():45-57. PubMed ID: 31097151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SDC2 and TFPI2 Methylation in Stool Samples as an Integrated Biomarker for Early Detection of Colorectal Cancer.
    Zhang W; Yang C; Wang S; Xiang Z; Dou R; Lin Z; Zheng J; Xiong B
    Cancer Manag Res; 2021; 13():3601-3617. PubMed ID: 33958894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA stool test for colorectal cancer: hypermethylation of the secreted frizzled-related protein-1 gene.
    Zhang W; Bauer M; Croner RS; Pelz JO; Lodygin D; Hermeking H; Stürzl M; Hohenberger W; Matzel KE
    Dis Colon Rectum; 2007 Oct; 50(10):1618-26; discussion 1626-7. PubMed ID: 17762966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of hypermethylated DNA or cyclooxygenase-2 messenger RNA in fecal samples of patients with colorectal cancer or polyps.
    Leung WK; To KF; Man EP; Chan MW; Hui AJ; Ng SS; Lau JY; Sung JJ
    Am J Gastroenterol; 2007 May; 102(5):1070-6. PubMed ID: 17378912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer.
    Glöckner SC; Dhir M; Yi JM; McGarvey KE; Van Neste L; Louwagie J; Chan TA; Kleeberger W; de Bruïne AP; Smits KM; Khalid-de Bakker CA; Jonkers DM; Stockbrügger RW; Meijer GA; Oort FA; Iacobuzio-Donahue C; Bierau K; Herman JG; Baylin SB; Van Engeland M; Schuebel KE; Ahuja N
    Cancer Res; 2009 Jun; 69(11):4691-9. PubMed ID: 19435926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene.
    Chen WD; Han ZJ; Skoletsky J; Olson J; Sah J; Myeroff L; Platzer P; Lu S; Dawson D; Willis J; Pretlow TP; Lutterbaugh J; Kasturi L; Willson JK; Rao JS; Shuber A; Markowitz SD
    J Natl Cancer Inst; 2005 Aug; 97(15):1124-32. PubMed ID: 16077070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter DNA methylation of oncostatin m receptor-beta as a novel diagnostic and therapeutic marker in colon cancer.
    Kim MS; Louwagie J; Carvalho B; Terhaar Sive Droste JS; Park HL; Chae YK; Yamashita K; Liu J; Ostrow KL; Ling S; Guerrero-Preston R; Demokan S; Yalniz Z; Dalay N; Meijer GA; Van Criekinge W; Sidransky D
    PLoS One; 2009 Aug; 4(8):e6555. PubMed ID: 19662090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of miR-34a and miR-34b/c in stool sample as potential screening biomarkers for noninvasive diagnosis of colorectal cancer.
    Wu XD; Song YC; Cao PL; Zhang H; Guo Q; Yan R; Diao DM; Cheng Y; Dang CX
    Med Oncol; 2014 Apr; 31(4):894. PubMed ID: 24573638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of stool DNA methylation in colorectal cancer diagnosis: A meta-analysis.
    Mojtabanezhad Shariatpanahi A; Yassi M; Nouraie M; Sahebkar A; Varshoee Tabrizi F; Kerachian MA
    PLoS One; 2018; 13(7):e0200735. PubMed ID: 30024936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of hypermethylated fibrillin-1 in the stool samples of colorectal cancer patients.
    Guo Q; Song Y; Zhang H; Wu X; Xia P; Dang C
    Med Oncol; 2013 Dec; 30(4):695. PubMed ID: 23963856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.